Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2008 3
2012 1
2016 2
2017 1
2018 1
2019 2
2020 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, Germinaro M, Huang KG, Shipitofsky N, Zhang H, Wilson R, Han C, Feagan BG, Sandborn WJ, Panés J, Hisamatsu T, Lichtenstein GR, Sands BE, Dignass A; QUASAR Study Group. Peyrin-Biroulet L, et al. Gastroenterology. 2023 Dec;165(6):1443-1457. doi: 10.1053/j.gastro.2023.08.038. Epub 2023 Sep 1. Gastroenterology. 2023. PMID: 37659673 Free article. Clinical Trial.
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.
Sandborn WJ, Feagan BG, Wolf DC, D'Haens G, Vermeire S, Hanauer SB, Ghosh S, Smith H, Cravets M, Frohna PA, Aranda R, Gujrathi S, Olson A; TOUCHSTONE Study Group. Sandborn WJ, et al. N Engl J Med. 2016 May 5;374(18):1754-62. doi: 10.1056/NEJMoa1513248. N Engl J Med. 2016. PMID: 27144850 Free article. Clinical Trial.
Half-life measurement of 65Ga with γ-spectroscopy.
Gyürky G, Halász Z, Kiss GG, Szücs T, Fülöp Z. Gyürky G, et al. Among authors: kiss gg. Appl Radiat Isot. 2019 Jun;148:87-90. doi: 10.1016/j.apradiso.2019.03.021. Epub 2019 Mar 20. Appl Radiat Isot. 2019. PMID: 30925368
Two-Proton Radioactivity of ^{67}Kr.
Goigoux T, Ascher P, Blank B, Gerbaux M, Giovinazzo J, Grévy S, Kurtukian Nieto T, Magron C, Doornenbal P, Kiss GG, Nishimura S, Söderström PA, Phong VH, Wu J, Ahn DS, Fukuda N, Inabe N, Kubo T, Kubono S, Sakurai H, Shimizu Y, Sumikama T, Suzuki H, Takeda H, Agramunt J, Algora A, Guadilla V, Montaner-Piza A, Morales AI, Orrigo SE, Rubio B, Fujita Y, Tanaka M, Gelletly W, Aguilera P, Molina F, Diel F, Lubos D, de Angelis G, Napoli D, Borcea C, Boso A, Cakirli RB, Ganioglu E, Chiba J, Nishimura D, Oikawa H, Takei Y, Yagi S, Wimmer K, de France G, Go S, Brown BA. Goigoux T, et al. Among authors: kiss gg. Phys Rev Lett. 2016 Oct 14;117(16):162501. doi: 10.1103/PhysRevLett.117.162501. Epub 2016 Oct 14. Phys Rev Lett. 2016. PMID: 27792367
β-Delayed One and Two Neutron Emission Probabilities Southeast of ^{132}Sn and the Odd-Even Systematics in r-Process Nuclide Abundances.
Phong VH, Nishimura S, Lorusso G, Davinson T, Estrade A, Hall O, Kawano T, Liu J, Montes F, Nishimura N, Grzywacz R, Rykaczewski KP, Agramunt J, Ahn DS, Algora A, Allmond JM, Baba H, Bae S, Brewer NT, Bruno CG, Caballero-Folch R, Calviño F, Coleman-Smith PJ, Cortes G, Dillmann I, Domingo-Pardo C, Fijalkowska A, Fukuda N, Go S, Griffin CJ, Ha J, Harkness-Brennan LJ, Isobe T, Kahl D, Khiem LH, Kiss GG, Korgul A, Kubono S, Labiche M, Lazarus I, Liang J, Liu Z, Matsui K, Miernik K, Moon B, Morales AI, Morrall P, Nepal N, Page RD, Piersa-Siłkowska M, Pucknell VFE, Rasco BC, Rubio B, Sakurai H, Shimizu Y, Stracener DW, Sumikama T, Suzuki H, Tain JL, Takeda H, Tarifeño-Saldivia A, Tolosa-Delgado A, Wolińska-Cichocka M, Woods PJ, Yokoyama R. Phong VH, et al. Among authors: kiss gg. Phys Rev Lett. 2022 Oct 21;129(17):172701. doi: 10.1103/PhysRevLett.129.172701. Phys Rev Lett. 2022. PMID: 36332266
Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.
Miehlke S, Aust D, Mihaly E, Armerding P, Böhm G, Bonderup O, Fernández-Bañares F, Kupcinskas J, Munck LK, Rehbehn KU, Nacak T, Greinwald R, Münch A; BUG-1/LMC Study Group. Miehlke S, et al. Gastroenterology. 2018 Dec;155(6):1795-1804.e3. doi: 10.1053/j.gastro.2018.08.042. Epub 2018 Sep 7. Gastroenterology. 2018. PMID: 30195447 Free article. Clinical Trial.
Coulomb suppression of the stellar enhancement factor.
Kiss GG, Rauscher T, Gyürky G, Simon A, Fülöp Z, Somorjai E. Kiss GG, et al. Phys Rev Lett. 2008 Nov 7;101(19):191101. doi: 10.1103/PhysRevLett.101.191101. Epub 2008 Nov 3. Phys Rev Lett. 2008. PMID: 19113257
Measurement of the -3 keV resonance in the reaction 13C(α,n)16O of importance in the s-process.
La Cognata M, Spitaleri C, Trippella O, Kiss GG, Rogachev GV, Mukhamedzhanov AM, Avila M, Guardo GL, Koshchiy E, Kuchera A, Lamia L, Puglia SM, Romano S, Santiago D, Spartà R. La Cognata M, et al. Among authors: kiss gg. Phys Rev Lett. 2012 Dec 7;109(23):232701. doi: 10.1103/PhysRevLett.109.232701. Epub 2012 Dec 4. Phys Rev Lett. 2012. PMID: 23368189
15 results